Perrigo Company plc Restructuring Reserve, Settled without Cash
Perrigo Company plc (PRGO) reported Restructuring Reserve, Settled without Cash of $200.00 thousand for the 3-month period ending 2022-04-02, per its 10-Q filed 2022-05-11.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveSettledWithoutCash2 · last filed 2022-05-11
- Perrigo Company plc restructuring reserve, settled without cash for the quarter ending 2022-04-02 was $200.00K, a 33.33% decline year-over-year.
- Perrigo Company plc restructuring reserve, settled without cash for the quarter ending 2021-10-02 was $100.00K.
- Perrigo Company plc restructuring reserve, settled without cash for the quarter ending 2021-07-03 was -$100.00K.
- Perrigo Company plc restructuring reserve, settled without cash for the quarter ending 2021-04-03 was $300.00K.
| Period end | Restructuring Reserve, Settled without Cash 3 month | Restructuring Reserve, Settled without Cash 3 month as first filed | Restructuring Reserve, Settled without Cash 6 month | Restructuring Reserve, Settled without Cash 6 month as first filed | Restructuring Reserve, Settled without Cash 9 month | Restructuring Reserve, Settled without Cash 9 month as first filed |
|---|---|---|---|---|---|---|
| 2022-04-02 | $200.00K 10-Q · filed 2022-05-11 | |||||
| 2021-10-02 | $100.00K 10-Q · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $200.00K 10-Q · filed 2021-11-12 | |||
| 2021-07-03 | -$100.00K 10-Q · filed 2021-08-11 | $100.00K 10-Q · filed 2021-08-11 | ||||
| 2021-04-03 | $300.00K 10-Q · filed 2022-05-11 | |||||
| 2020-09-26 | -$200.00K 10-Q · filed 2021-11-12 | -$200.00K derived: sum of 2 quarters · filed 2021-11-12 | -$200.00K 10-Q · filed 2021-11-12 | |||
| 2020-06-27 | $0.00 10-Q · filed 2021-08-11 | $0.00 10-Q · filed 2021-08-11 | $100.00K 10-Q · filed 2020-08-05 | |||
| 2020-03-28 | $0.00 10-Q · filed 2021-05-12 | $100.00K 10-Q · filed 2020-05-05 | ||||
| 2019-09-28 | $500.00K 10-Q · filed 2020-11-05 | $200.00K derived: sum of 2 quarters · filed 2020-11-05 | $800.00K 10-Q · filed 2020-11-05 | |||
| 2019-06-29 | -$300.00K 10-Q · filed 2020-08-05 | $100.00K 10-Q · filed 2020-08-05 | ||||
| 2019-03-30 | $400.00K 10-Q · filed 2020-05-05 | -$400.00K 10-Q · filed 2019-05-09 | ||||
| 2018-09-29 | $0.00 10-Q · filed 2019-11-06 | $300.00K derived: sum of 2 quarters · filed 2019-11-06 | $200.00K 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $300.00K 10-Q · filed 2019-08-08 | $100.00K 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | $300.00K 10-Q · filed 2019-05-09 | |||||
| 2017-09-30 | -$400.00K 10-Q · filed 2018-11-08 | $400.00K 10-Q · filed 2017-11-09 | -$100.00K derived: sum of 2 quarters · filed 2018-11-08 | $700.00K 10-Q · filed 2018-11-08 | -$700.00K 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $300.00K 10-Q · filed 2018-08-09 | -$300.00K 10-Q · filed 2017-08-10 | $100.00K 10-Q · filed 2018-08-09 | -$100.00K 10-Q · filed 2017-08-10 | ||
| 2017-04-01 | $200.00K 10-Q · filed 2018-05-08 | |||||
| 2016-10-01 | $100.00K 10-Q · filed 2017-11-09 | $100.00K derived: sum of 2 quarters · filed 2017-11-09 | $5.00M 10-Q · filed 2017-11-09 | |||
| 2016-07-02 | $0.00 10-Q · filed 2017-08-10 | $5.00M 10-Q · filed 2017-08-10 | ||||
| 2016-04-02 | $5.10M 10-Q · filed 2017-05-30 | |||||
| 2015-09-26 | -$700.00K 10-Q · filed 2016-11-10 | -$700.00K derived: sum of 2 quarters · filed 2017-05-22 | -$500.00K 10-Q · filed 2016-11-10 | |||
| 2015-06-27 | $0.00 10-Q/A · filed 2017-05-22 | $0.00 10-Q/A · filed 2017-05-22 | ||||
| 2015-03-28 | $0.00 10-Q/A · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |